Travere Therapeutics, Inc (TVTX): SCHEDULE 13G/A filed Feb 13, 2026

Form type

SCHEDULE 13G/A

Filing date

Feb 13, 2026

Accession number

0001193125-26-049707

Filer

Travere Therapeutics, Inc (CIK 1438533)